New Delhi: In a major development that would help drug makers to tide over the high costs of Active Pharmaceutical Ingredients (APIs) and intermediates, the National Pharmaceutical Pricing Authority (NPPA) has increased the ceiling price of 21 formulations by 50 percent on Dec.13.
NPPA said it has been receiving applications for an upward revision of prices under para 19 of the Drug Price Control Orders (DPCO), 2013, since the last two years. The applications cited various reasons such as an increase in API costs, an increase in the cost of production, exchange rates etc. resulting in the unviability of the production and marketing of certain drugs.
